نتایج جستجو برای: anaplastic thyroid cancer

تعداد نتایج: 979026  

Journal: :The Journal of clinical endocrinology and metabolism 2005
Rosanna Sorrentino Silvana Libertini Pier Lorenzo Pallante Giancarlo Troncone Lucio Palombini Vassilios Bavetsias Daniela Spalletti-Cernia Paolo Laccetti Spiros Linardopoulos Paolo Chieffi Alfredo Fusco Giuseppe Portella

Alterations in chromosome number (aneuploidy) are common in human neoplasias. Loss of mitotic regulation is believed to induce aneuploidy in cancer cells and act as a driving force during the malignant progression. The serine/theronine protein kinases of aurora family genes play a critical role in the regulation of key cell cycle processes. Aurora B mediates chromosome segregation by ensuring o...

Journal: :Cancer research 2011
Avaniyapuram Kannan Murugan Mingzhao Xing

Thyroid cancer is the most common endocrine cancer, and targeted approaches to treat it pose considerable interest. In this study, we report the discovery of ALK gene mutations in thyroid cancer that may rationalize clinical evaluation of anaplastic lymphoma kinase (ALK) inhibitors in this setting. In undifferentiated anaplastic thyroid cancer (ATC), we identified two novel point mutations, C35...

2017
Hyung Kwon Byeon Hwi Jung Na Yeon Ju Yang Sooah Ko Sun Och Yoon Minhee Ku Jaemoon Yang Jae Wook Kim Myung Jin Ban Ji-Hoon Kim Da Hee Kim Jung Min Kim Eun Chang Choi Chang-Hoon Kim Joo-Heon Yoon Yoon Woo Koh

Previously, the authors have identified that c-Met mediates reactivation of the PI3K/AKT pathway following BRAF inhibitor treatment in BRAF (V600E) mutant anaplastic thyroid cancer, thereby contributing to the acquired drug resistance. Therefore dual inhibition of BRAF and c-Met led to sustained treatment response, thereby maximizing the specific anti-tumor effect of targeted therapy. The prese...

Journal: :International Journal of Endocrinology 2014

Journal: :Archives of Otolaryngology–Head & Neck Surgery 2003

2012
Shu-Fu Lin Yu-Yao Huang Jen-Der Lin Ting-Chao Chou Chuen Hsueh Richard J. Wong

BACKGROUND We assessed the utility of the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) as single agent therapy and in combination with conventional chemotherapy for thyroid cancer. METHODOLOGY/PRINCIPAL FINDINGS Eight cell lines from four types of thyroid cancer (papillary, follicular, anaplastic, medullary) were studied. The cytotoxicity of BEZ235 and five conventional chemotherapeutic agent...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید